Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage

AIMS: With the arrival of conventional synthetic (csDMARDs), biological (bDMARDS) and then targeted synthetic (tsDMARDs) disease-modifying anti-rheumatic drugs, the therapeutic arsenal against rheumatoid arthritis (RA) has recently expanded. However, there are still some unmet needs for patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaess, Julien, Walther, Julia, Petitdemange, Arthur, Gottenberg, Jacques-Eric, Sibilia, Jean, Arnaud, Laurent, Felten, Renaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747097/
https://www.ncbi.nlm.nih.gov/pubmed/33403019
http://dx.doi.org/10.1177/1759720X20959971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747097/
https://www.ncbi.nlm.nih.gov/pubmed/33403019
http://dx.doi.org/10.1177/1759720X20959971

Ejemplares similares